The Biggest News of 2020: TCTMD’s Top 10
COVID-19 infected our entire top 10 list this year, speaking to the need among readers to learn as much as they could, and quickly.
No big surprise: our top 10 stories for 2020 were all related to COVID-19. The range of topics speaks to the need among our readers to discover as much as possible about how the virus was directly affecting the heart or, as was the case for story #1, causing unexpected consequences. Our fourth most popular “story” for the year was actually one we updated continuously: the COVID-19 Daily Dispatch. It launched back in March and ultimately spanned 10 URLs, one for every month. Links to Dispatch content for times gone by can be found at the foot of each month.
As COVID-19 cases go global, a picture is emerging as to its CV impact and how cardiologists in hard-hit regions are coping.
The data support the idea that some patients may need anticoagulation to prevent pulmonary embolism.
Every weekday since March 23, 2020, we’ve been summing up the top research and policy news on COVID-19. Here, we link to the current month’s Dispatch. Find all of TCTMD’s past Dispatches here.
A new era for telemedicine, rebuilding patient trust, and an increase in efficiency of care were common themes.
Be prepared, experts urge. Much is still unknown about how the novel coronavirus will affect day-to-day and emergency CVD care.
Experts stress there is not enough evidence to suggest these medications can worsen COVID-19 morbidity and mortality.
A new review explores the higher risk of thrombotic disease with this coronavirus, how to prevent and treat it, plus research gaps.
A BMJ editorial notes obesity is a modifiable risk factor for COVID-19, calling for reformulation of processed foods and a ban on ads.
How the immune response tips so radically off-balance is unclear, but research, some drawing on recent CVD trials, ploughs on.
* * *
COVID-19 may have been the most-searched term of 2020, but cardiology stories still had their day in the sun. Our top five “non-COVID” stories of the year were:
Despite popular belief, coconut oil has no anti-inflammatory or glycemic benefits, leading experts to discourage its consumption.
All-cause mortality is the most “unbiased” primary endpoint, the authors argue. David Kandzari calls this an oversimplification.
Americans tend to consume far less olive oil than their Mediterranean counterparts, but beneficial signals are still seen.
Physicians had a range of reactions to TAVR trial criticisms, but Society of Thoracic Surgeons leaders say they stand for balanced discourse.
Steven Nissen argues REDUCE-IT gave a “false-positive” result. But Deepak Bhatt, that study's PI, calls the assertion “ridiculous.”